NAMPT and neoplasm: A recent meta-analysis of 14 studies encompassing 1616 patients revealed increased expression of visfatin in various cancers and the association of this adipokine with poorer overall survival, as well as with tumor size, tumor stage, and the presence of lymph nodes or distant metastases [175].